Researching-Alzheimers-Medicines-Setbacks-and-Stepping-Stones

A teaser image of a fact sheet from PhRMA titled "Researching Alzheimer's Medicines: Setbacks and Stepping Stones"

More than 6 million Americans, most of them age 65 or older, live with Alzheimer’s disease, a devastating degenerative brain disease and the most common form of dementia. Despite the immense challenges to research, biopharmaceutical companies remain committed.

A teaser image of a fact sheet from PhRMA titled "Researching Alzheimer's Medicines: Setbacks and Stepping Stones"